the pooled data revealed that satisfactory responses were obtained in 80 % of urinary tract infections , 91 % of intraabdominal infections , 91 % of obstetric and gynecologic infections , 92 % of lower respiratory tract infections , 92 % of skin and skin-structure infections , 90 % of bone and joint infections , and 94 % of bacteremic infections .
C0262950
bone
C0157749
joint infections